National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Minnesota Department of Health, St Paul, MN, USA.
Clin Microbiol Infect. 2017 Aug;23(8):574.e7-574.e14. doi: 10.1016/j.cmi.2017.02.021. Epub 2017 Feb 28.
Our objective was to evaluate and exploit a whole genome sequence (WGS) bioinformatics pipeline for predicting antimicrobial resistance and capsular serotypes from invasive group B streptococci (iGBS).
For 1975 iGBS recovered during 2015 from CDC's Active Bacterial Core surveillance, we compared pipeline predictions with broth dilution testing. Fifty-six isolates from earlier surveillance were included for testing β-lactams. Conventional serotyping was compared to WGS-based assignments for 302 isolates.
All 28 isolates with reduced susceptibility to β-lactam antibiotics harboured one of 19 rare PBP2x types. Resistances to erythromycin/clindamycin (808/1975 isolates, 41.0%), erythromycin (235/1975, 11.9%) and lincosamide/streptogramin A/pleuromutilins (56/1975, 2.8%) were predicted by the presence of erm-methylase, mef and lsa determinants, respectively (41 of 56 lsa gene-positive isolates also contained lnu, erm and/or mef genes). Presence of both erm and lsa determinants (25 isolates) predicted non-susceptibility to quinupristin/dalfopristin. Most isolates (1680/1975, 85.1%) were tet gene-positive, although 41/1565 (2.6%) tetM-positive isolates were tetracycline-susceptible. All 53 fluoroquinolone-resistant isolates contained ParC and/or GyrA substitutions. Resistances to rifampin (eight isolates), trimethoprim, chloramphenicol and vancomycin (two isolates each) were predicted by the pipeline. Resistance to macrolides/lincosamides without pipeline prediction was rare and correlated to divergent resistance genes or rRNA A2062G substitution. A selection of 267 isolates assigned WGS-based serotypes were also conventionally serotyped. Of these, 246 (92.1%) were in agreement, with the remaining 21 (7.8%) conventionally non-serotypeable. For 32 of 1975 isolates (1.6%), WGS-based serotypes could not be assigned.
The WGS-based assignment of iGBS resistance features and serotypes is an accurate substitute for phenotypic testing.
我们的目的是评估和利用全基因组序列(WGS)生物信息学管道,以预测侵袭性 B 组链球菌(iGBS)的抗生素耐药性和荚膜血清型。
对于 2015 年 CDC 主动细菌核心监测中回收的 1975 株 iGBS,我们将管道预测与肉汤稀释试验进行了比较。为了测试β-内酰胺,还纳入了 56 株来自早期监测的分离株。比较了 302 株分离株的常规血清型与基于 WGS 的分配。
所有对β-内酰胺抗生素敏感性降低的 28 株分离株均携带 19 种罕见 PBP2x 型之一。对红霉素/克林霉素(1975 株中的 808 株,41.0%)、红霉素(1975 株中的 235 株,11.9%)和林可酰胺/链阳性菌素 A/磷霉素(1975 株中的 56 株,2.8%)的耐药性分别由 erm-甲基酶、mef 和 lsa 决定因素预测(56 株 lsa 基因阳性分离株中有 41 株也含有 lnu、erm 和/或 mef 基因)。erm 和 lsa 决定因素的存在(25 株)预测对奎奴普丁/达福普汀的不敏感性。大多数分离株(1975 株中的 1680 株,85.1%)tet 基因阳性,尽管 1565 株 tetM 阳性分离株中有 41 株对四环素敏感。所有 53 株氟喹诺酮耐药株均含有 ParC 和/或 GyrA 取代。管道预测了对利福平(8 株)、甲氧苄啶、氯霉素和万古霉素(各 2 株)的耐药性。预测到对大环内酯类/林可酰胺类的耐药性,而没有管道预测,这与不同的耐药基因或 rRNA A2062G 取代有关。还对基于 WGS 的血清型进行了常规血清分型的 267 株分离株的选择。其中,246 株(92.1%)一致,其余 21 株(7.8%)常规不可分型。对于 1975 株分离株中的 32 株(1.6%),无法基于 WGS 分配血清型。
iGBS 耐药特征和血清型的 WGS 赋值是表型检测的准确替代方法。